The brand’s BiomeAge products will be available with a patented mixing ampoule.
Beauty Packaging Staff01.15.25
Young Pharmaceuticals, a leading provider of physician-dispensed skincare products, has entered an exclusive distribution agreement with LAC2βiome S.r.l., a maker of microbial based product solutions in Milan, Italy.
The first product line available will be BiomeAge for private labeling by dispensing physicians. BiomeAge will be packaged in a patented mixing ampoule and include a patent-pending formula that combines Hyaluronic acid with live Lactobacilli.
LAC2βiome CEO & Co-Founder Lasse Nagell said,
“We are committed to offering solution-based microbial products for the medical aesthetics market. We are pleased to partner with Young as we share a similar focus on science-driven product development and overall excitement for microbial based skincare solutions.”
The first product line available will be BiomeAge for private labeling by dispensing physicians. BiomeAge will be packaged in a patented mixing ampoule and include a patent-pending formula that combines Hyaluronic acid with live Lactobacilli.
LAC2βiome CEO & Co-Founder Lasse Nagell said,
“We are committed to offering solution-based microbial products for the medical aesthetics market. We are pleased to partner with Young as we share a similar focus on science-driven product development and overall excitement for microbial based skincare solutions.”
Read Next
Haut.AI Launches SkinGPT for Virtual Skincare Try-Ons
CosRx Launches Alpha-Arbutin 2 Skin Discoloration Serum
Eucerin Launches Radiant Tone Collection
